Logo image of MBLY

MOBILEYE GLOBAL INC-A (MBLY) Stock Fundamental Analysis

USA - NASDAQ:MBLY - US60741F1049 - Common Stock

13.03 USD
+0.18 (+1.4%)
Last: 10/31/2025, 1:14:06 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to MBLY. MBLY was compared to 83 industry peers in the Automobile Components industry. MBLY has a great financial health rating, but its profitability evaluates not so good. MBLY is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

MBLY had positive earnings in the past year.
MBLY had a positive operating cash flow in the past year.
MBLY had negative earnings in each of the past 5 years.
In the past 5 years MBLY always reported a positive cash flow from operatings.
MBLY Yearly Net Income VS EBIT VS OCF VS FCFMBLY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 -1B -2B -3B

1.2 Ratios

Looking at the Return On Assets, with a value of -2.69%, MBLY is doing worse than 80.72% of the companies in the same industry.
MBLY's Return On Equity of -2.82% is on the low side compared to the rest of the industry. MBLY is outperformed by 73.49% of its industry peers.
Industry RankSector Rank
ROA -2.69%
ROE -2.82%
ROIC N/A
ROA(3y)-8.42%
ROA(5y)-5.38%
ROE(3y)-8.77%
ROE(5y)-5.6%
ROIC(3y)N/A
ROIC(5y)N/A
MBLY Yearly ROA, ROE, ROICMBLY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -5 -10 -15 -20 -25

1.3 Margins

MBLY has a better Gross Margin (48.66%) than 97.59% of its industry peers.
MBLY's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for MBLY so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 48.66%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.76%
GM growth 5Y-1.42%
MBLY Yearly Profit, Operating, Gross MarginsMBLY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

8

2. Health

2.1 Basic Checks

MBLY does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for MBLY has been increased compared to 1 year ago.
MBLY has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
MBLY Yearly Shares OutstandingMBLY Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 200M 400M 600M 800M
MBLY Yearly Total Debt VS Total AssetsMBLY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

An Altman-Z score of 11.39 indicates that MBLY is not in any danger for bankruptcy at the moment.
MBLY's Altman-Z score of 11.39 is amongst the best of the industry. MBLY outperforms 95.18% of its industry peers.
There is no outstanding debt for MBLY. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 11.39
ROIC/WACCN/A
WACC8.79%
MBLY Yearly LT Debt VS Equity VS FCFMBLY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.3 Liquidity

MBLY has a Current Ratio of 6.46. This indicates that MBLY is financially healthy and has no problem in meeting its short term obligations.
With an excellent Current ratio value of 6.46, MBLY belongs to the best of the industry, outperforming 96.39% of the companies in the same industry.
A Quick Ratio of 5.61 indicates that MBLY has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 5.61, MBLY belongs to the top of the industry, outperforming 96.39% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 6.46
Quick Ratio 5.61
MBLY Yearly Current Assets VS Current LiabilitesMBLY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

6

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 7.50% over the past year.
MBLY shows a small growth in Revenue. In the last year, the Revenue has grown by 7.61%.
The Revenue has been growing by 13.48% on average over the past years. This is quite good.
EPS 1Y (TTM)7.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-10%
Revenue 1Y (TTM)7.61%
Revenue growth 3Y6.07%
Revenue growth 5Y13.48%
Sales Q2Q%3.7%

3.2 Future

The Earnings Per Share is expected to grow by 53.27% on average over the next years. This is a very strong growth
Based on estimates for the next years, MBLY will show a very strong growth in Revenue. The Revenue will grow by 26.63% on average per year.
EPS Next Y40.46%
EPS Next 2Y32.52%
EPS Next 3Y37.54%
EPS Next 5Y53.27%
Revenue Next Year12.08%
Revenue Next 2Y10.78%
Revenue Next 3Y15.45%
Revenue Next 5Y26.63%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
MBLY Yearly Revenue VS EstimatesMBLY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B
MBLY Yearly EPS VS EstimatesMBLY Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.5 1 1.5 2 2.5

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 30.30 indicates a quite expensive valuation of MBLY.
Based on the Price/Earnings ratio, MBLY is valued a bit more expensive than 63.86% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.19, MBLY is valued at the same level.
Based on the Price/Forward Earnings ratio of 29.68, the valuation of MBLY can be described as expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of MBLY indicates a slightly more expensive valuation: MBLY is more expensive than 73.49% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of MBLY to the average of the S&P500 Index (22.50), we can say MBLY is valued slightly more expensively.
Industry RankSector Rank
PE 30.3
Fwd PE 29.68
MBLY Price Earnings VS Forward Price EarningsMBLY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, MBLY is valued a bit more expensive than 79.52% of the companies in the same industry.
60.24% of the companies in the same industry are more expensive than MBLY, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 16.88
EV/EBITDA 62.87
MBLY Per share dataMBLY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10

4.3 Compensation for Growth

MBLY's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
MBLY's earnings are expected to grow with 37.54% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.75
PEG (5Y)N/A
EPS Next 2Y32.52%
EPS Next 3Y37.54%

0

5. Dividend

5.1 Amount

No dividends for MBLY!.
Industry RankSector Rank
Dividend Yield N/A

MOBILEYE GLOBAL INC-A

NASDAQ:MBLY (10/31/2025, 1:14:06 PM)

13.03

+0.18 (+1.4%)

Chartmill FA Rating
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)10-23 2025-10-23/bmo
Earnings (Next)01-28 2026-01-28/amc
Inst Owners53.36%
Inst Owner Change0.4%
Ins Owners2.12%
Ins Owner Change22.12%
Market Cap10.60B
Revenue(TTM)1.94B
Net Income(TTM)-336000000
Analysts73.71
Price Target19.63 (50.65%)
Short Float %15.21%
Short Ratio4.63
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)12.99%
Min EPS beat(2)2.78%
Max EPS beat(2)23.2%
EPS beat(4)4
Avg EPS beat(4)11.44%
Min EPS beat(4)2.78%
Max EPS beat(4)23.2%
EPS beat(8)7
Avg EPS beat(8)7.16%
EPS beat(12)11
Avg EPS beat(12)15.37%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)2.92%
Min Revenue beat(2)2.68%
Max Revenue beat(2)3.17%
Revenue beat(4)3
Avg Revenue beat(4)1.27%
Min Revenue beat(4)-1.33%
Max Revenue beat(4)3.17%
Revenue beat(8)6
Avg Revenue beat(8)0.85%
Revenue beat(12)7
Avg Revenue beat(12)0.51%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.59%
PT rev (3m)-3.05%
EPS NQ rev (1m)1.48%
EPS NQ rev (3m)54.96%
EPS NY rev (1m)1.09%
EPS NY rev (3m)12.44%
Revenue NQ rev (1m)0.35%
Revenue NQ rev (3m)13.85%
Revenue NY rev (1m)0.27%
Revenue NY rev (3m)4.15%
Valuation
Industry RankSector Rank
PE 30.3
Fwd PE 29.68
P/S 5.47
P/FCF 16.88
P/OCF 15.3
P/B 0.89
P/tB 4.31
EV/EBITDA 62.87
EPS(TTM)0.43
EY3.3%
EPS(NY)0.44
Fwd EY3.37%
FCF(TTM)0.77
FCFY5.92%
OCF(TTM)0.85
OCFY6.54%
SpS2.38
BVpS14.67
TBVpS3.02
PEG (NY)0.75
PEG (5Y)N/A
Graham Number11.91
Profitability
Industry RankSector Rank
ROA -2.69%
ROE -2.82%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 48.66%
FCFM 32.4%
ROA(3y)-8.42%
ROA(5y)-5.38%
ROE(3y)-8.77%
ROE(5y)-5.6%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.76%
GM growth 5Y-1.42%
F-Score7
Asset Turnover0.16
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 12.65%
Cap/Sales 3.35%
Interest Coverage N/A
Cash Conversion 541.41%
Profit Quality N/A
Current Ratio 6.46
Quick Ratio 5.61
Altman-Z 11.39
F-Score7
WACC8.79%
ROIC/WACCN/A
Cap/Depr(3y)18.23%
Cap/Depr(5y)20.31%
Cap/Sales(3y)5.18%
Cap/Sales(5y)7.06%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)7.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-10%
EPS Next Y40.46%
EPS Next 2Y32.52%
EPS Next 3Y37.54%
EPS Next 5Y53.27%
Revenue 1Y (TTM)7.61%
Revenue growth 3Y6.07%
Revenue growth 5Y13.48%
Sales Q2Q%3.7%
Revenue Next Year12.08%
Revenue Next 2Y10.78%
Revenue Next 3Y15.45%
Revenue Next 5Y26.63%
EBIT growth 1Y-4.04%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year125.39%
EBIT Next 3Y52.25%
EBIT Next 5Y49.57%
FCF growth 1Y90.88%
FCF growth 3Y-11.23%
FCF growth 5Y4.5%
OCF growth 1Y58.95%
OCF growth 3Y-12.59%
OCF growth 5Y5.92%

MOBILEYE GLOBAL INC-A / MBLY FAQ

What is the fundamental rating for MBLY stock?

ChartMill assigns a fundamental rating of 5 / 10 to MBLY.


What is the valuation status of MOBILEYE GLOBAL INC-A (MBLY) stock?

ChartMill assigns a valuation rating of 3 / 10 to MOBILEYE GLOBAL INC-A (MBLY). This can be considered as Overvalued.


Can you provide the profitability details for MOBILEYE GLOBAL INC-A?

MOBILEYE GLOBAL INC-A (MBLY) has a profitability rating of 2 / 10.


Can you provide the financial health for MBLY stock?

The financial health rating of MOBILEYE GLOBAL INC-A (MBLY) is 8 / 10.


What is the earnings growth outlook for MOBILEYE GLOBAL INC-A?

The Earnings per Share (EPS) of MOBILEYE GLOBAL INC-A (MBLY) is expected to grow by 40.46% in the next year.